SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000902664-19-003736
Filing Date
2019-09-16
Accepted
2019-09-16 17:06:45
Documents
10
Effectiveness Date
2019-09-16

Document Format Files

Seq Description Document Type Size
1 AMAG PHARMACEUTICALS, INC. p19-1940dfan14a.htm DFAN14A 27507
2 GRAPHIC image_001.jpg GRAPHIC 174484
3 GRAPHIC image_002.jpg GRAPHIC 182289
4 GRAPHIC image_003.jpg GRAPHIC 189069
5 GRAPHIC image_004.jpg GRAPHIC 133796
6 GRAPHIC image_005.jpg GRAPHIC 152690
7 GRAPHIC image_006.jpg GRAPHIC 96341
8 GRAPHIC image_007.jpg GRAPHIC 210039
9 GRAPHIC image_008.jpg GRAPHIC 48947
10 GRAPHIC image_009.jpg GRAPHIC 298190
  Complete submission text file 0000902664-19-003736.txt   2076944
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-10865 | Film No.: 191095207
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 MADISON AVENUE NEW YORK NY 10022
Business Address 520 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A